TLDR Blocking miR-27a increases sheep hair follicle stem cell growth and decreases cell death, which could help improve wool quality and treat hair loss.
The study "miR-27a Targeting PIK3R3 Regulates the Proliferation and Apoptosis of Sheep Hair Follicle Stem Cells" found that miR-27a, a type of microRNA, plays a significant role in the proliferation and apoptosis of hair follicle stem cells (HFSCs) in sheep. This is achieved by miR-27a targeting and downregulating the PIK3R3 gene, which subsequently reduces the activity of the AKT/MTOR pathway, leading to decreased HFSC proliferation and increased apoptosis. Conversely, inhibiting miR-27a led to increased PIK3R3, AKT, and MTOR expression, enhancing HFSC proliferation and reducing apoptosis. These findings suggest that miR-27a could be a crucial regulator of sheep HFSC proliferation and apoptosis, potentially providing insights for improving wool quality and developing new treatments for hair loss conditions.
117 citations
,
November 2006 in “Experimental Dermatology”
The article concludes that the wool follicle is a valuable model for studying tissue interactions and has potential for genetic improvements in wool production.
A new stemcell method for culturing hairfollicles is being developed as an alternative to Minoxidil, finasteride, and RU58841. There are concerns about its cost and accessibility despite plans for commercialization.
PP405, a topical LDH inhibitor, has shown to stimulate hairfolliclestemcell proliferation in humans with moderate hair loss. They are advancing to more detailed trials this year.
A breakthrough in hairfollicle cultivation using induced pluripotent stemcells (iPSCs) has been achieved, producing large hairfollicles suitable for transplantation. Clinical trials for this hair multiplication technology are planned in partnership with Yinguan Biotechnology.
Hairfollicles are mostly dormant but can be reactivated with treatments like minoxidil, finasteride, and microneedling. A new drug, PP405, shows promise for hair regrowth but may not be available until 2027-2028.
A potential non-invasive topical treatment targeting the WNT Signaling Pathway for hair regeneration is being researched, with positive results on human hairfolliclecells. Current effective treatments for hair loss include Minoxidil, finasteride, and hair transplantation.
